Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 0.00% is 100% below its 5-year average of 42.81%, near the low end of its 5-year range (0.00%–100.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
53.77%
GROSS MARGIN AVG 5Y
42.81%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.63%
median of 726 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$90.97M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$89.99M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$89.34M
Gross Margin
40.32%
TTM Avg
35.69%
3Y Avg
34.43%
5Y Avg
37.90%
Market Cap
$89.32M
Gross Margin
89.28%
TTM Avg
-3011.26%
3Y Avg
-1505.63%
5Y Avg
-1003.75%
Market Cap
$93.28M
Gross Margin
10.89%
TTM Avg
14.00%
3Y Avg
13.41%
5Y Avg
13.41%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Equillium, Inc. (EQ) | $90.73M | 0.00% | 0.00% | 53.77% | 42.81% |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $90.97M | 0.00% | 0.00% | 0.00% | 0.00% |
| electroCore, Inc. (ECOR)vs › | $91.33M | 87.06% | 85.86% | 83.85% | 76.72% |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.99M | 0.00% | 0.00% | 0.00% | 0.00% |
| ImmuCell Corporation (ICCC)vs › | $89.34M | 40.32% | 35.69% | 34.43% | 37.90% |
| Rallybio Corporation (RLYB)vs › | $89.32M | 89.28% | -3011.26% | -1505.63% | -1003.75% |
| Biomea Fusion, Inc. (BMEA)vs › | $93.01M | 0.00% | 0.00% | 0.00% | 0.00% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.28M | 10.89% | 14.00% | 13.41% | 13.41% |
| CareCloud, Inc. (CCLD)vs › | $86.47M | 46.51% | 45.81% | 42.58% | 41.06% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $85.42M | 82.44% | 83.07% | -40.55% | -241.44% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 100.00% |
| 2024-09-30 | 100.00% |
| 2024-06-30 | 100.00% |
| 2024-03-31 | 99.70% |
| 2023-12-31 | 99.64% |
| 2023-09-30 | 100.00% |
| 2023-06-30 | 99.66% |
| 2023-03-31 | 100.00% |
| 2022-12-31 | 100.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
